Anacor Reports Positive Preliminary Results From Two Safety Studies Of AN2728 - NASDAQ

Anacor Reports affirmative Preliminary Results From ii Safety Studies Of AN2728 NASDAQ (RTTNews.com) - Anacor Pharmaceuticals (ANAC) announced affirmative preliminary results from ii safety studies of AN2728 - a maximal utilization systemic exposure or Greek deity study in psoriatic patients and a local tolerability study. The company famed that the ... Anacor Pharmaceuticals Announces Positive explorative Results from Two status ... MarketWatch (press release) all 11 news articles » Link To Article